Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases

Pharmacoeconomic evaluation of treatment in patients with Helicobacter pylori-associated diseases

AIM. To estimate the pharmacoeconomic parameters of treatment in patients with Helicobacter pylori-associated diseases when using 6 eradication therapy (ET) regimens. MATERIALS AND METHODS. The investigation enrolled a total of 231 patients who received anti-Helicobacter pylori therapy according to...

Full description

Bibliographic Details
Main Authors: A A Samsonov, V B Grechushnikov, D N Andreev, G L Iurenev, T I Korovina, Iu A Lezhneva, I V Maev
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-08-01
Series:Терапевтический архив
Subjects:
helicobacter pylori
eradication therapy
proton pump inhibitors
bismuth tripotassium dicitrate
effective cost coefficient
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31556

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31556

Similar Items